These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35267493)

  • 21. Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data.
    Mamatjan Y; Agnihotri S; Goldenberg A; Tonge P; Mansouri S; Zadeh G; Aldape K
    J Mol Diagn; 2017 Nov; 19(6):881-891. PubMed ID: 28867603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and transfer of spatial transcriptomics signatures for cancer diagnosis.
    Yoosuf N; Navarro JF; Salmén F; Ståhl PL; Daub CO
    Breast Cancer Res; 2020 Jan; 22(1):6. PubMed ID: 31931856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and Localization of Solid Tumors Utilizing the Cancer-Type-Specific Mutational Signatures.
    Wang Z; Zhang T; Wu W; Wu L; Li J; Huang B; Liang Y; Li Y; Li P; Li K; Wang W; Guo R; Wang Q
    Front Bioeng Biotechnol; 2022; 10():883791. PubMed ID: 35547159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparametric magnetic resonance imaging-derived deep learning network to determine ferroptosis-related gene signatures in gliomas.
    Zuo Z; Liu W; Zeng Y; Fan X; Li L; Chen J; Zhou X; Jiang Y; Yang X; Feng Y; Lu Y
    Front Neurosci; 2022; 16():1082867. PubMed ID: 36605558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network.
    Lee K; Jeong HO; Lee S; Jeong WK
    Sci Rep; 2019 Nov; 9(1):16927. PubMed ID: 31729414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
    Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
    Front Immunol; 2022; 13():900273. PubMed ID: 36159856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting cancer origins with a DNA methylation-based deep neural network model.
    Zheng C; Xu R
    PLoS One; 2020; 15(5):e0226461. PubMed ID: 32384093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer.
    Cao R; Yang F; Ma SC; Liu L; Zhao Y; Li Y; Wu DH; Wang T; Lu WJ; Cai WJ; Zhu HB; Guo XJ; Lu YW; Kuang JJ; Huan WJ; Tang WM; Huang K; Huang J; Yao J; Dong ZY
    Theranostics; 2020; 10(24):11080-11091. PubMed ID: 33042271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TULIP: An RNA-seq-based Primary Tumor Type Prediction Tool Using Convolutional Neural Networks.
    Jones S; Beyers M; Shukla M; Xia F; Brettin T; Stevens R; Weil MR; Ranganathan Ganakammal S
    Cancer Inform; 2022; 21():11769351221139491. PubMed ID: 36507076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.
    Peng L; Bian XW; Li DK; Xu C; Wang GM; Xia QY; Xiong Q
    Sci Rep; 2015 Aug; 5():13413. PubMed ID: 26292924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators.
    Simeone I; Ceccarelli M
    J Transl Med; 2023 Jan; 21(1):55. PubMed ID: 36717859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DeepTRIAGE: interpretable and individualised biomarker scores using attention mechanism for the classification of breast cancer sub-types.
    Beykikhoshk A; Quinn TP; Lee SC; Tran T; Venkatesh S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):20. PubMed ID: 32093737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.
    Ding W; Chen G; Shi T
    Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-Cancer Survival Classification With Clinicopathological and Targeted Gene Expression Features.
    Zhao D; Kim DY; Chen P; Yu P; Ho S; Cheng SW; Zhao C; Guo JA; Li YR
    Cancer Inform; 2021; 20():11769351211035137. PubMed ID: 34376966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic pan-cancer classification using image-based deep learning.
    Ye T; Li S; Zhang Y
    Comput Struct Biotechnol J; 2021; 19():835-846. PubMed ID: 33598099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers.
    Pane K; Affinito O; Zanfardino M; Castaldo R; Incoronato M; Salvatore M; Franzese M
    Front Genet; 2020; 11():612521. PubMed ID: 33424936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.
    Xu Q; Chen J; Ni S; Tan C; Xu M; Dong L; Yuan L; Wang Q; Du X
    Mod Pathol; 2016 Jun; 29(6):546-56. PubMed ID: 26990976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome and Biomarker Supervised Deep Learning for Survival Prediction in Two Multicenter Breast Cancer Series.
    Bychkov D; Joensuu H; Nordling S; Tiulpin A; Kücükel H; Lundin M; Sihto H; Isola J; Lehtimäki T; Kellokumpu-Lehtinen PL; von Smitten K; Lundin J; Linder N
    J Pathol Inform; 2022; 13():9. PubMed ID: 35136676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.